Wealthspire Advisors (New York)’s Sarepta Therapeutics SRPT Stock Holding History

Wealthspire Advisors (New York)’s Portfolio SRPT Stock Details SRPT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$11.4K	Buy
2020 Q2	–	Sell
2020 Q1	$250K	Buy